ADAM17 and COVID-19: Crucially, cleavage of ACE2 by TMPRSS2 after virus spike protein attachment allows SARS‐CoV‐2 to enter cells,2 whereas ACE2 cleavage by ADAM17 does not facilitate entry,3, 4 although ADAM17 may mediate COVID‐19 severity.5